首页> 外文期刊>Medicinski Preglad >Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease
【24h】

Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease

机译:急性缺血性脑病患者脑脊液和血浆中神经元特异性烯醇化酶

获取原文
           

摘要

The objective of this research was to determine the dynamics of change of neuron-specific enolase concentration in patients with acute ischemic brain disease in cerebrospinal fluid and plasma. The study included 103 patients, their mean age 58-66 years. The control group consisted of 16 patients, of matching age and sex, with radicular lesions of discal origin, subjected to diagnostic radiculography. Concentration of neuron-specific enolase was measured by a flouroimmunometric method. The results showed that the concentration of neuron-specific enolase in cerebrospinal fluid and plasma of patients with brain ischemic disease within first seven days significantly increased compared to the control. The highest increase of concentration was established in brain infarction, somewhat lower in reversible ischemic attack, and the lowest in transient ischemic attack. Maximal concentration was established on the 3rd-4th day upon the brain infarction. Neuron-specific enolase concentration in cerebrospinal fluid and plasma may be an indicator of pathophysiological processes in the acute phase of brain ischemia and is significant in early diagnostics and therapy of the disease.
机译:这项研究的目的是确定脑脊髓液和血浆中急性缺血性脑病患者神经元特异性烯醇化酶浓度变化的动态。该研究包括103名患者,他们的平均年龄为58-66岁。对照组包括16名年龄和性别相匹配的,具有椎间盘根源性放射病变的患者,接受了放射学X线摄影检查。通过荧光免疫法测量神经元特异性烯醇化酶的浓度。结果显示,与对照组相比,脑缺血性疾病患者在头7天内脑脊液和血浆中神经元特异性烯醇化酶的浓度显着增加。在脑梗死中浓度升高最高,在可逆性缺血发作中较低,而在短暂性缺血发作中最低。在脑梗塞后的第3-4天建立最大浓度。脑脊液和血浆中神经元特异性烯醇化酶的浓度可能是脑缺血急性期病理生理过程的指标,对疾病的早期诊断和治疗具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号